HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

GRENYHGCTTHWGFTLC peptide

Also Known As:

CTT2 peptide

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - GRENYHGCTTHWGFTLC peptide: 1
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - GRENYHGCTTHWGFTLC peptide: 1

Experts

1.	Heikkilä, Pia: 1 article (05/2006)
2.	Koivunen, Erkki: 1 article (05/2006)
3.	Pirilä, Emma: 1 article (05/2006)
4.	Salo, Tuula: 1 article (05/2006)
5.	Sorsa, Timo: 1 article (05/2006)
6.	Suojanen, Juho: 1 article (05/2006)
7.	Väänänen, Anu: 1 article (05/2006)

Related Diseases

1.	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/01/2006 - "In this study, we demonstrate that both the new hydrophilic derivate GRENYHGCTTHWGFTLC (CTT2) peptide and the CTT1 peptide inhibited specifically the human tongue squamous cell carcinoma (HSC-3) cell-derived gelatinolytic activity and in vitro invasion and migration of these cells (p < or = 0.049). "

Related Drugs and Biologics

1.	CTTHWGFTLC peptide